Dr. Rajat Saha

MBBS, MD, DNB (Medical Oncology)

Sr. Consultant and Unit Head – Medical Oncology

Book an Appointment

RGCIRC, Rohini, Delhi - 110085

RGCIRC, Niti Bagh, Delhi - 110049

About

Dr. Rajat Saha is a compassionate medical oncologist with a special interest in Head and neck oncology, neuro-oncology and Breast oncology. He considers that holistic treatment of cancer starts with prevention and lifestyle modifications. A team player believes that the field of oncology can improve through collaborative research.

He has gathered a rich experience of over 15 years in oncology and is credited with imparting knowledge to Oncology students across India.

Specialized Areas

Head and neck oncology
Neuro-Oncology
Breast oncology
Geriatric oncology (cancers in the elderly)

Educational Background

MBBS: Grant Medical College, Mumbai
MD Medicine: Grant Medical College, Mumbai
DNB Medical Oncology: RGCIRC, Delhi

Experience

Sr. Consultant & Unit Head, RGCIRC, Delhi: 2023 – till date
Associate Director, Medical Oncology at Max Superspeciality hospital, Patparganj & Vaishali: 2016 – 2023
Senior Consultant, Medical Oncology at Max Superspeciality hospital, Delhi: 2014 – 2016
Consultant in Medical Oncology at BLK Superspeciality hospital, Delhi: 2011 – 2014
Consultant in Medical Oncology, RGCIRC, Delhi: 2011 – 2011
DNB residency program in Medical Oncology, RGCIRC, Delhi: 2008 – 2011
Senior Resident in Medical Oncology, RGCIRC, Delhi: 2007 – 2008
Senior Resident in Nephrology, Sir J.J Group of Hospitals, Mumbai: 2006 – 2006
MD Medicine program at Grant medical college and Sir J.J group of hospitals: 2003 – 2006
Junior resident in Medicine at GTB Hospital, Delhi: 2002 – 2002

Professional Journey

Achievements

National oncology quiz master credited with holding regional and national level oncology quizzes
Co-investigator in international multicenter trial of Sativex- a transmucosal cannabinoid spray for the control of cancer related pain.
Co-Investigator in Novartis sponsored multicenter trial of Buparlisib- oral PI3K inhibitor in recurrent head and neck cancers.

Publication

Letter to editor: Chemotherapy-Induced Palmoplantar Erythrodysesthesia in a Child with Burkitt Lymphoma, Pediatric Blood & Cancer, 2009.
Chapter titled ‘CML- Overview and Recent Advances’ in APICON yearbook 2010.
Chapter titled ‘Targeted therapy in Lung Cancer’ in Lung Cancer year book 2012.
Case report: Mediastinal Gray zone lymphoma, The Indian Journal of Chest Diseases & Allied Sciences, 2015: 57;255-257.